Consolidated Financial Highlights

21F

First Quarter

July 30th, 2021

TSE Code:6737

Disclaimer Regarding Forward-looking Statements

Any statements in this document, other than those of historical fact, are forward-looking statements about the future performance of EIZO and its group companies, which are based on management's assumptions and beliefs in light of information currently available, and involve apparent or potential risks and uncertainties including forex impact, and risks related to supply and demand. Actual results may differ materially from these forecasts.

Note: "21Q1" appearing in this presentation means "First Quarter Fiscal year 2021".

"21F" appearing in this presentation means "Fiscal year 2021", that is Fiscal year ended March 31, 2022.

Details of the Market Group

Market Group

Market / Use

Business & Plus (B&P)

Financial institutions , Public authorities , Educational facilities , CAD , Commercial facilities , Business and

home use

Healthcare (HC)

Diagnosis / Medical examination , Medical treatment / Operation , Healthcare-IT

Creative Work (CW)

Media & Entertainment , 3D computer graphics , Photo editing , Illustration , Design , Publication / Printing

For various mission critical environments, infrastructure and industrial equipment

Vertical & Specific (V&S)

Air traffic control (ATC) , Maritime , Security & Surveillance (S&S) , MIL-STD compliance & Other industrial

fields (including touch panel applications)

Amusement (AMU)

LCD-mounted pachinko and slot machines

Other (OTH)

Maintenance services and commissioned development of software

1

21F, First Quarter

© 2021 EIZO Corporation. All Rights Reserved.

Contents

  1. 21Q1 Consolidated Financial Results
  2. 21F Plan / Topics
  3. Reference Materials

2

21F, First Quarter

© 2021 EIZO Corporation. All Rights Reserved.

21Q1 Consolidated Financial Highlights

Sales & Operating Income Increased

Steady Sales in B&P, HC & CW. Increasing Sales in AMU.

  • Under severe supply conditions caused by the shortage of semiconductors, our inventory strategy ensured we could continue stable supply contributing to strong sales.
  • B&P: Overseas sales were steady mainly in Europe due to high investment in IT equipment.
    Sales in Japan increased because of capital investment previously postponed.

◼ HC: Overseas sales were steady due to a healthy demand for diagnostic and endoscopy applications. Sales in Japan recovered slightly as hospitals eased entry restrictions.

    • AMU： In a slow market, sales increased due to new compliance regulations and previously postponed sales due to the temporary closure of pachinko parlors nationwide in 20Q1.
  • Operating Income increased significantly. Gross profit ratio increased by 5.7pt compared to 20Q1. SG&A increased as expenses in 20Q1 for sales & marketing were controlled strictly.

3

21F, First Quarter

© 2021 EIZO Corporation. All Rights Reserved.

(JPY Million) Consolidated Income Statement

20Q1

21Q1

QoQ

Net Sales

14,098

23,151

164.2%

Gross Profit

4,613

8,890

192.7%

Gross Profit / Net Sales

32.7%

38.4%

5.7pt

Selling, General and

4,441

4,850

109.2%

Administrative Expenses

Operating Income

171

4,039

2,355.3%

Operating Income / Net Sales

1.2%

17.4%

16.2pt

Ordinary Income

585

4,579

781.9%

Net Income Attributable to

390

3,166

811.1%

EIZO Corporation's Stockholders

Exchange Rate(Quarterly Ave.):USD

JPY107.63

JPY109.52

JPY1.89

Exchange Rate(Quarterly Ave.):EUR

JPY118.58

JPY131.94

JPY13.36

4

21F, First Quarter

© 2021 EIZO Corporation. All Rights Reserved.

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Eizo Corporation published this content on 30 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 July 2021 07:08:05 UTC.